Regulation of AMPK/SIRT1/PGC-1α-mediated oxidative stress and mitochondrial dynamics by paeoniflorin might be a potential pharmacological approach to target CKD skeletal muscle atrophy. This evidence concerns the gene PPARGC1A and chronic kidney disease.